Back to Screener

Healthcare

Ligand Pharmaceuticals, Inc.(LGNDZ)

Live Price

Offline

$0.0013

+0.00% today

1Y Change

-48.00%

Window

Jul 1, 2025 โ†’ Jun 10, 2026

Market Cap
$4.68B
Revenue Growth
+60.4%
EPS Growth
+1188.0%
Dividend Yield
0.0%

Coverage: 12 bars ยท Jul 1, 2025 โ†’ Jun 10, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Ligand Pharmaceuticals, Inc. (LGNDZ) is a Healthcare stock with a market cap of $4.68B and listed on OTC. The stock last traded around $0.00 and down 48.0% across the available one-year price window (Jul 1, 2025 โ†’ Jun 10, 2026). Baseline metrics include revenue growth of +60.4%, EPS growth of +1188.0%, a dividend yield of 0.0%. What stands out right now is revenue +60.4%, EPS +1188.0%, free cash flow -48.6% with operating margin 17.6% and ROIC 2.4%. Valuation already assumes a fairly strong business story at P/E 37.2 and price/sales 17.5. Stock Foundry combines LGNDZ price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Edge

LGNDZ vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

LGNDZ

โ€”

Normalized return

SPY

--

S&P 500

Excess Return

--

Relative to SPY

LGNDZ Max Drawdown

-89.92%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for LGNDZ and SPY.

Calendar-year return history is still loading or unavailable.

Earnings Reports

๐Ÿ“… Last reportedMay 6, 2026
PeriodB/MEPSEPS ฮ”RevenueRev ฮ”Report
โ€”
May 6, 26
โ€”
Est 1.84
โ€”
โ€”
Est 59099.2B
โ€”
May 6
โ€”
Feb 26, 26
โœ“
2.02
Est 1.50
+34.7%
59666.0B
Est 55588.9B
+7.3%
Feb 26
โ€”
Nov 6, 25
โœ“
5.18
Est 1.93
+168.4%
115461.0B
Est 58743.9B
+96.5%
Nov 6
โ€”
May 5, 25
โœ—
-2.21
Est 1.21
-282.8%
45333.0B
Est 44304.8B
+2.3%
May 5
โ€”
Feb 25, 25
โœ—
-1.70
Est 1.19
-242.8%
42812.0B
Est 39025.9B
+9.7%
Feb 25
โ€”
Nov 7, 24
โœ—
-0.39
Est 1.35
-128.8%
51812.0B
Est 39011.6B
+32.8%
Nov 7
โ€”
Aug 6, 24
โœ—
-2.88
Est 1.06
-371.6%
41531.0B
Est 33038.2B
+25.7%
Aug 6
โ€”
May 7, 24
โœ“
4.75
Est 0.83
+469.5%
30978.0B
Est 27923.5B
+10.9%
May 7
โ€”
Mar 14, 24
โœ“
1.03
Est 0.66
+55.8%
28101.0B
Est 25645.0B
+9.6%
Mar 14
โ€”
Nov 9, 23
โœ—
-0.59
Est 0.62
-195.3%
32868.0B
Est 27224.0B
+20.7%
Nov 9
โ€”
Aug 9, 23
โœ—
0.13
Est 0.64
-79.7%
26366.0B
Est 24738.8B
+6.6%
Aug 9
โ€”
May 8, 23
2.33
Est โ€”
โ€”
43979.0B
Est โ€”
โ€”
May 8
โ€”
Feb 28, 23
-1.04
Est โ€”
โ€”
50382.0B
Est โ€”
โ€”
Feb 28
โ€”
Nov 8, 22
0.02
Est โ€”
โ€”
66088.0B
Est โ€”
โ€”
Nov 8
โ€”
Aug 9, 22
-0.05
Est โ€”
โ€”
57419.0B
Est โ€”
โ€”
Aug 9
โ€”
May 9, 22
-0.91
Est โ€”
โ€”
45693.0B
Est โ€”
โ€”
May 9
โ€”
Feb 28, 22
-0.30
Est โ€”
โ€”
72473.0B
Est โ€”
โ€”
Feb 28
โ€”
Nov 9, 21
0.80
Est โ€”
โ€”
64835.0B
Est โ€”
โ€”
Nov 9
โ€”
Aug 2, 21
1.79
Est โ€”
โ€”
84675.0B
Est โ€”
โ€”
Aug 2
โ€”
May 6, 21
1.05
Est โ€”
โ€”
55150.0B
Est โ€”
โ€”
May 6
No upcoming earnings in the next 90 days

Next Step

Connect reports to catalysts

Earnings pages get much more useful when they are tied back to upcoming dates, expectations, and peer setups.

Read the earnings calendar guideOpen the calendar screener